The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| AFGVY | +72.18% | -75.61% | -24.57% | -61% |
| S&P | +12.9% | +73.65% | +11.66% | +677% |
Agfa-Gevaert NV engages in the development, manufacture, and distribution of analogue and digital systems for the printing industry, the healthcare sector, and specific industrial applications. It operates through the following segments: HealthCare IT, Radiology Solutions, Digital Print and Chemicals, and Offset Solutions. The HealthCare IT segment focuses on imaging data management. The Radiology Solutions segment provides analog and digital imaging technology. The Digital Print and Chemicals segment supplies sign and display printing companies with inkjet printers with matched inks. The Offset Solutions segment offers commercial, newspaper, and packaging printers, and prepress and printing solutions. The company was founded on June 10, 1964 and is headquartered in Mortsel, Belgium.
No news articles found for Agfa-Gevaert.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $300.34M | -1.3% |
| Gross Profit | $80.64M | -10.5% |
| Gross Margin | 26.85% | -2.8% |
| Market Cap | $211.33M | 5.0% |
| Market Cap / Employee | $46.08K | 0.0% |
| Employees | 4.6K | 0.0% |
| Net Income | -$21,035.28K | -59.6% |
| EBITDA | $4.67M | -57.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $76.38M | 20.1% |
| Accounts Receivable | $259.68M | -3.5% |
| Inventory | 358.4 | -6.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $191.53M | 6.6% |
| Short Term Debt | $16.45M | 5.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -4.84% | -2.6% |
| Return On Invested Capital | -16.48% | 1.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $27.92M | 455.9% |
| Operating Free Cash Flow | $38.71M | 513.4% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.26 | 0.26 | 0.04 | 0.58 | 17.50% |
| Price to Sales | 0.09 | 0.13 | 0.16 | 0.14 | -8.18% |
| Price to Tangible Book Value | 0.78 | 0.78 | 0.24 | 2.37 | 74.07% |
| Price to Free Cash Flow TTM | 6.67 | - | |||
| Enterprise Value to EBITDA | 3.63 | -68.45 | 8.57 | 64.97 | 123.90% |
| Free Cash Flow Yield | 15.0% | - | |||
| Return on Equity | -25.4% | -28.2% | -17.2% | -20.1% | 152.45% |
| Total Debt | $161.54M | $200.92M | $244.16M | $207.98M | 6.49% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
